Navigation Links
Local Research Foundation Achieves Milestone in Fight Against Cancer
Date:10/23/2008

CHRISTUS Stehlin Foundation for Cancer Research Develops Innovative

Anticancer Drug

HOUSTON, Oct. 23 /PRNewswire/ -- Almost everyone knows the devastation that cancer brings to families, workplaces and communities, and many Houstonians are aware of well-known local cancer treatment institutions. Few, however, may be familiar with the CHRISTUS Stehlin Foundation for Cancer Research, a nationally recognized leader in cancer research located in Houston, which recently achieved a milestone in their battle against cancer.

The CHRISTUS Stehlin Foundation recently received word from the Food and Drug Administration that CZ48, a promising anticancer drug they discovered and developed, was approved to begin Phase I (human) clinical trials. This is a large step in the journey to offer this potentially lifesaving drug to people suffering from cancer.

This is a remarkable accomplishment, since past records show that for every 5,000 to 10,000 oncology compounds discovered, only 250 make it to pre-clinical phases, and only five (one-tenth of one percent) are approved by the FDA for these human studies.

CZ48 is a derivative of extracts from a Chinese tree, the Camptotheca Acuminata, which more than 45 years ago showed potent anticancer activity against a type of mouse leukemia. The Stehlin Foundation has been researching cancer treatment with the Camptothecin family of compounds since 1988, and as a pioneer in the development of the Camptothecin family of drugs, has synthesized and tested more than 200 Camptothecin derivatives. In fact, the New York Academy of Science wrote, "Camptothecins can be envisioned as the ultimate anticancer drugs when fully developed."

The first phase of the trial has begun at the University of New Mexico Cancer Center in Albuquerque, N.M., and plans are also under way to offer the trial at Vanderbilt-Ingram Cancer Center in Nashville, Tenn. This phase of the clinical trial process
'/>"/>

SOURCE CHRISTUS Stehlin Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
2. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
3. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
4. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
5. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
6. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
7. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Sarnova, parent company ... of the new www.tri-anim.com website, continuing ... healthcare distributor of respiratory, anesthesia and other critical ... The site has many new features ... making online shopping and ordering easier and more ...
(Date:3/2/2015)... , March 2, 2015  Tandem Diabetes Care®, Inc. ... and manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... public offering of common stock have exercised their option ... stock at a price to the public of $11.50 ... offering is expected to be $64.8 million, after deducting ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 Aurora Fit ... celebration and charity drive to observe the opening of the ... charity organization Ashleigh’s Hope. The event will be held on ... S #7, Aurora, ON. The opening will feature free boot ... Fit Body Boot Camp is the world’s most popular and ...
(Date:3/2/2015)... Formetco today announced the official launch ... FTX uses state-of-the-art technology to deliver an outdoor advertising ... satisfaction. An item of particular value, and previously ... year LED Brightness Warranty. , Why the FTX was ... billboard among any other billboard product in the world. ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Dr. David ... injury, is partnering with Doctors on Liens ... patients. It’s rare for personal injury victims to ... and especially on a lien basis. However, San ... outstanding team of chiropractors, M.D., pain management physician, massage, ...
(Date:3/2/2015)... New York, NY (PRWEB) March 02, 2015 ... a long history of catalyzing private sector activities ... that it has recently elected four new members ... , GBCHealth welcomes Dr. Paul Farmer, Chief Strategist ... University Professor at Harvard University; Dr. Huma Abbasi, ...
(Date:3/2/2015)... 02, 2015 “ Wants and Needs ... monthly AppWatch, which features the latest and coolest mobile ... Tropeano, a mobile technology expert and host of NewsWatch, ... this app helps people evaluate priorities. , Whether a ... Wants and Needs app. The app allows people to ...
Breaking Medicine News(10 mins):Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 2Health News:Aurora Fit Body Boot Camp Celebrates Grand Opening with Charity Fundraiser 3Health News:Formetco Launches Innovative LED Billboard System 2Health News:Distinguished Doctor Brings His Multi-Specialty Medical Group to Doctors on Liens in San Diego 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2
... Recent researcher has shown that there is no link ... over the past few years has suggested vaccinations that ... polio, diphtheria and other diseases might be putting children ... ,Studies have shown countries where childhood vaccinations are ...
... coronavirus. Similar viruses infect the pigs and other animals. It ... more than two dozen countries on four continents before it ... were sickened, and at least 774 died.Civet cats and other ... southern China are suspected of spreading SARS to humans although ...
... exercising and the prevention and survival rates of certain ... results from nearly 850 women with endometrial cancer, aged ... of exercise activity during their adolescent and adult years.Results ... life were up to 40 percent less likely to ...
... Latest researcher show that a few alcoholic beverages a ... disease in men // with high blood pressure. ... had a significantly lower risk of death by nearly ... a reduced risk of cardiovascular disease death as alcohol ...
... cancer patients by 63 percent with their latest drug ... trial strengthens the case for administering the newer drug, ... women recovering from breast cancer lowered their chance of ... to exemestane after two or three years of tamoxifen ...
... Sports and Exercise and the Center for Asthma and Allergy Care, ... 18-year olds who had at least one risk factor for asthma. ... risk factor noted by children was a family member having allergies ... 10 minutes. Forced expiratory volume ( FEV ) was measured at ...
Cached Medicine News:Health News:SARS vaccine shows promise in Animal Testing 2
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... test kit is a solid phase enzyme ... is designed for the quantitative measurement of ... serum or plasma. The microplate is coated ... and patient samples are pipetted into the ...
Free T3 EIA Thyroid Function 025-BC-1006...
Prolactin EIA Reproductive Markers 025-BC-1037...
Medicine Products: